BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31390885)

  • 1. Prognostic Value of the Geriatric Nutritional Risk Index in Patients Exceeding 70 Years Old with Esophageal Squamous Cell Carcinoma.
    Wang Y; Wang L; Fang M; Li J; Song T; Zhan W; Xu H
    Nutr Cancer; 2020; 72(4):620-626. PubMed ID: 31390885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of pre-therapeutic nutritional risk factors in elderly patients with locally advanced esophageal squamous cell carcinoma receiving definitive chemoradiotherapy or radiotherapy.
    Qiu J; Yang J; Yu Y; Wang Z; Lin H; Ke D; Zheng H; Li J; Yao Q
    BMC Cancer; 2023 Jun; 23(1):597. PubMed ID: 37380982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of hemoglobin combined with Geriatric Nutritional Risk Index scores in patients undergoing postoperative radiotherapy for esophageal squamous cell carcinoma.
    Wang B; Xu C; Ying K; Chu J; Geng W
    Future Oncol; 2022 Jan; 18(2):179-191. PubMed ID: 34870444
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of geriatric nutritional risk index on surgical outcomes after esophagectomy in patients with esophageal cancer.
    Kubo N; Sakurai K; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Yashiro M; Ohira M
    Esophagus; 2019 Apr; 16(2):147-154. PubMed ID: 30311102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geriatric Nutritional Risk Index as a prognostic factor in patients with esophageal squamous cell carcinoma -retrospective cohort study.
    Yamana I; Takeno S; Shimaoka H; Yamashita K; Yamada T; Shiwaku H; Hashimoto T; Yamashita Y; Hasegawa S
    Int J Surg; 2018 Aug; 56():44-48. PubMed ID: 29602015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of consolidation chemotherapy following definitive chemoradiotherapy in patients with esophageal squamous cell cancer.
    Wu SX; Li XY; Xu HY; Xu QN; Luo HS; Du ZS; Huang HC; Wu ZY
    Sci Rep; 2017 Dec; 7(1):16870. PubMed ID: 29203855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma.
    Sugawara K; Yagi K; Okumura Y; Nishida M; Aikou S; Yamashita H; Yamashita H; Seto Y
    Int J Clin Oncol; 2020 Apr; 25(4):552-560. PubMed ID: 31828451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma.
    Dai H; Shao YW; Tong X; Wu X; Pang J; Feng A; Yang Z
    Cancer Med; 2020 Mar; 9(5):1628-1637. PubMed ID: 31851786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Significance of the Geriatric Nutritional Risk Index in Patients with Esophageal Squamous Cell Carcinoma.
    Migita K; Matsumoto S; Wakatsuki K; Ito M; Kunishige T; Nakade H; Sho M
    Nutr Cancer; 2018; 70(8):1237-1245. PubMed ID: 30235009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Preoperative Nutritional Indexes for Outcomes after Primary Esophageal Surgery for Esophageal Squamous Cell Carcinoma.
    Yoon JP; Nam JS; Abidin MFBZ; Kim SO; Lee EH; Choi IC; Chin JH
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of geriatric nutritional risk index in esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy.
    Feng J; Wang L; Yang X; Chen Q; Cheng X
    Eur J Surg Oncol; 2024 Jun; 50(6):108323. PubMed ID: 38603867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of clinical outcomes and prognostic factors in patients treated with definitive chemoradiotherapy for oesophageal squamous cell carcinoma.
    Jeong H; Im HS; Bang Y; Kim YH; Kim HR; Lee HJ; Jung HY; Lee GH; Song HJ; Kim DH; Choi KD; Lee JH; Ahn JY; Na HK; Ryu JS; Kang J; Kim SB; Kim JH; Park SR
    Cancer Med; 2021 Mar; 10(5):1745-1758. PubMed ID: 33590710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy.
    Pao TH; Chang WL; Chiang NJ; Chang JS; Lin CY; Lai WW; Tseng YL; Yen YT; Chung TJ; Lin FC
    Radiat Oncol; 2020 Sep; 15(1):221. PubMed ID: 32962730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Nutrition-Related Factor-Based Risk Stratification for Exploring the Clinical Benefits in the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: A Retrospective Cohort Study.
    Yu Y; Wu H; Qiu J; Ke D; Wu Y; Lin M; Liu T; Zheng Q; Zheng H; Yang J; Wang Z; Li H; Liu L; Yao Q; Li J; Cheng W; Chen X
    Front Nutr; 2022; 9():896847. PubMed ID: 35990358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of the planned neoadjuvant radiotherapy or chemoradiotherapy for the non-radical resection of esophageal squamous cell carcinoma].
    Ni WJ; Deng W; Xiao ZF; Zhou ZM; Wang X; Chen DF; Feng QF; Liang J; Lyu JM; Bi N; Deng L; Zhang T; Wang WQ; Xue Q; Gao SG; Mu JW; Mao YS; Wang DL; Zhao J; Gao YS; Huang JF; Tan FW; Zhao L; Lyu F; Zhang GC
    Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):295-302. PubMed ID: 31014056
    [No Abstract]   [Full Text] [Related]  

  • 16. Short-term response might influence the treatment-related benefit of adjuvant chemotherapy after concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients.
    Liu A; Wang Y; Wang X; Zhu L; Nie Y; Li M
    Radiat Oncol; 2021 Oct; 16(1):195. PubMed ID: 34600574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes and prognostic factors for esophageal cancer in patients aged 80 years or older who were treated with definitive radiotherapy and chemoradiotherapy.
    Takahashi N; Umezawa R; Kishida K; Yamamoto T; Ishikawa Y; Takeda K; Suzuki Y; Kawabata K; Teramura S; Jingu K
    Esophagus; 2022 Jan; 19(1):129-136. PubMed ID: 34476633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of the systemic immune-inflammation index for predicting survival in esophageal squamous cell carcinoma after radical radiotherapy.
    Wang Y; Lyu J; Jia H; Liang L; Xiao L; Liu Y; Liu X; Li K; Chen T; Zhang R; Zhang H; Tang C; Li T
    Future Oncol; 2021 Jul; 17(20):2647-2657. PubMed ID: 34008415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
    Wang WT; Guo CQ; Cui GH; Zhao S
    World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of lymph node to primary tumor standardized uptake value ratio in unresectable esophageal cancer.
    Chen PJ; Yap WK; Chang YC; Tseng CK; Chao YK; Hsieh JC; Pai PC; Lee CH; Yang CK; Ho AT; Hung TM
    BMC Cancer; 2020 Jun; 20(1):545. PubMed ID: 32522275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.